This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Source: Campbell AP, Ogokeh C, Lively JY, et al. Vaccine effectiveness against pediatric influenza hospitalizations and emergency visits [published online ahead of print October 5, 2020]. Pediatrics. doi: 10.1542/peds.2020-1368
Investigators from multiple institutions conducted an observational study to estimate influenza vaccine effectiveness (VE) during the 2018–2019 influenza season among children treated in pediatric hospitals and EDs. Children were eligible if they presented to one of the 7 US pediatric hospitals with <14 days of fever, cough, otalgia, nasal congestion, rhinorrhea, pharyngitis, myalgias, post-tussive vomiting, wheezing, dyspnea, apnea, or brief resolved unexplained events during the 2018–2019 influenza season. At enrollment, a nasal and throat swab was obtained for testing for influenza A subtypes, including A(H3N2) and A(H1N1)pdm09, and B lineage. Cases were defined as children who were hospitalized or had an ED visit and had a swab positive for …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Purchase access
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.